Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Sales | 12,719 | 16,613 | 10,387 | 9,809 | 19,332 |
| Cost of Goods | 8,100 | 7,414 | 6,536 | 8,515 | N/A |
| Gross Profit | 4,619 | 9,199 | 3,851 | 1,294 | 19,332 |
| Operating Expenses | 87,518 | 105,968 | 142,774 | 237,738 | 177,632 |
| Operating Income | -82,799 | -96,355 | -138,387 | -235,929 | -158,300 |
| Interest Expense | 14,309 | 21,681 | 18,718 | 5,454 | 3,520 |
| Other Income | -12,116 | -6,498 | 3,901 | 3,810 | 18,654 |
| Pre-tax Income | -109,224 | -124,534 | -153,204 | -237,573 | -143,166 |
| Net Income Continuous | -109,224 | -124,534 | -153,204 | -237,573 | -143,166 |
| Net Income | $-109,224 | $-124,534 | $-153,204 | $-237,573 | $-143,166 |
| EPS Basic Total Ops | -8.00 | -11.40 | -18.20 | -32.40 | -23.10 |
| EPS Basic Continuous Ops | -7.85 | -11.37 | -18.16 | -32.17 | -22.80 |
| EPS Diluted Total Ops | -8.00 | -11.40 | -18.20 | -32.40 | -23.10 |
| EPS Diluted Continuous Ops | -7.85 | -11.37 | -18.16 | -32.17 | -22.80 |
| EBITDA(a) | $-71,237 | $-83,258 | $-123,454 | $-221,284 | $-149,369 |